{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:02:36Z","timestamp":1789624956310,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antiresorptive therapy (AR) disrupts osseous homeostasis and can induce direct irritation over the gastrointestinal mucosa; however, its\u00a0possible erosive effects on the oral epithelium have not been totally described. Among the most frequent oral erosive lesions, oral lichen planus (OLP) frequently presents as painful mucosal ulcerations, arising from basal membrane inflammatory damage. Thus, the aim of this retrospective study was to describe the association between AR and the incidence of OLP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This case-control study included data from 148 patients (17 patients undergoing AR therapy (AR group) \/ 131 without AR therapy (Control group)). Each patient record was systematically processed and the association between AR drugs and OLP clinical characteristics within both groups was assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The erosive form of OLP was significantly more frequent in the AR group than in the Control group (<jats:italic>p<\/jats:italic>\u2009=\u20090.029). Indeed, the AR treatment using alendronic acid (41.2%) was the most frequently reported. Additionally, the erosive form of OLP showed the strongest association with pain and burning sensation among the OLP types (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.050). However, disease worsening and AR consumption were not significantly associated (<jats:italic>p<\/jats:italic>\u2009=\u20090.150).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients under AR therapy show more clinical symptoms associated to the erosive type of OLP. Regardless of the AR therapy, the erosive type of OLP is associated with more severe symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-024-04331-5","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T14:01:25Z","timestamp":1715349685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of antiresorptive therapy on the prevalence and severity of oral lichen planus: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Puria","family":"Parvini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Obreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio A.","family":"Cafferata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Aini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanislava","family":"Lermen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Begic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"issue":"Suppl 18","key":"4331_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/clr.13282","volume":"29","author":"A Stavropoulos","year":"2018","unstructured":"Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schi\u00f8dt M, Klinge B. The effect of antiresorptive drugs on implant therapy: systematic review and meta-analysis. Clin Oral Implants Res. 2018;29(Suppl 18):54\u201392. https:\/\/doi.org\/10.1111\/clr.13282.","journal-title":"Clin Oral Implants Res"},{"issue":"9","key":"4331_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"14","key":"4331_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","volume":"335","author":"PC de Groen","year":"1996","unstructured":"de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335(14):1016\u201321. https:\/\/doi.org\/10.1056\/NEJM199610033351403.","journal-title":"N Engl J Med"},{"key":"4331_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bonr.2016.06.001","volume":"5","author":"A Modi","year":"2016","unstructured":"Modi A, Fan CS, Tang J, Weaver JP, Sajjan S. Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: an observational study. Bone Rep. 2016;5:208\u201313. https:\/\/doi.org\/10.1016\/j.bonr.2016.06.001. Published 2016 Jun 7.","journal-title":"Bone Rep"},{"issue":"4","key":"4331_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.joms.2011.03.046","volume":"70","author":"M Kharazmi","year":"2012","unstructured":"Kharazmi M, Sjoqvist K, Warfvinge G. Oral ulcers, a little known adverse effect of alendronate: review of the literature. J Oral Maxillofac Surg. 2012;70(4):830\u20136. https:\/\/doi.org\/10.1016\/j.joms.2011.03.046.","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"4331_CR6","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.joms.2012.01.025","volume":"70","author":"M Kharazmi","year":"2012","unstructured":"Kharazmi M, Persson U, Warfvinge G. Pharmacovigilance of oral bisphosphonates: adverse effects manifesting in the soft tissue of the oral cavity. J Oral Maxillofac Surg. 2012;70(12):2793\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"4331_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1034\/j.1600-0714.2000.291006.x","volume":"29","author":"MA Gonzalez-Moles","year":"2000","unstructured":"Gonzalez-Moles MA, Bagan-Sebastian JV. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med. 2000;29(10):514\u20138. https:\/\/doi.org\/10.1034\/j.1600-0714.2000.291006.x.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"4331_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","volume":"44","author":"IR Reid","year":"2009","unstructured":"Reid IR. Osteonecrosis of the jaw: who gets it, and why? Bone. 2009;44(1):4\u201310. https:\/\/doi.org\/10.1016\/j.bone.2008.09.012.","journal-title":"Bone"},{"issue":"5","key":"4331_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/odi.12154","volume":"20","author":"E Donetti","year":"2014","unstructured":"Donetti E, Gualerzi A, Sardella A, Lodi G, Carrassi A, Sforza C. Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa. Oral Dis. 2014;20(5):466\u201372. https:\/\/doi.org\/10.1111\/odi.12154.","journal-title":"Oral Dis"},{"key":"4331_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2018\/7645465","volume":"2018","author":"RAG Khammissa","year":"2018","unstructured":"Khammissa RAG, Chandran R, Masilana A, Lemmer J, Feller L. Adverse immunologically mediated oral mucosal reactions to systemic medication: lichenoid tissue reaction\/interface dermatitis-stomatitis, autoimmune vesiculobullous disease, and ige-dependent and immune complex reactions. J Immunol Res. 2018;2018:10. https:\/\/doi.org\/10.1155\/2018\/7645465. PMID: 29984259; PMCID: PMC6015680.","journal-title":"J Immunol Res"},{"issue":"1","key":"4331_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/prd.12260","volume":"80","author":"M Carrozzo","year":"2019","unstructured":"Carrozzo M, Porter S, Mercadante V, Fedele S. Oral lichen planus: a disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies. Periodontol 2000. 2019;80(1):105\u201325. https:\/\/doi.org\/10.1111\/prd.12260.","journal-title":"Periodontol 2000"},{"issue":"4","key":"4331_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1834-7819.2002.tb00540.x","volume":"47","author":"PB Sugerman","year":"2002","unstructured":"Sugerman PB, Savage NW. Oral lichen planus: causes, diagnosis and management. Aust Dent J. 2002;47(4):290\u20137.","journal-title":"Aust Dent J"},{"issue":"2","key":"4331_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1067\/mjd.2002.120452","volume":"46","author":"D Eisen","year":"2002","unstructured":"Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46(2):207\u201314.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4331_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.oooo.2016.03.011","volume":"122","author":"ZB Kurago","year":"2016","unstructured":"Kurago ZB. Etiology and pathogenesis of oral lichen planus: an overview. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(1):72\u201380.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4331_CR15","doi-asserted-by":"crossref","unstructured":"El-Howati A, Thornhill MH, Colley HE, Murdoch C. Immune mechanisms in oral lichen planus. Oral Dis. 2022;29(4):1400\u201315.","DOI":"10.1111\/odi.14142"},{"issue":"1","key":"4331_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00784-010-0507-6","volume":"16","author":"AM Pabst","year":"2012","unstructured":"Pabst AM, Ziebart T, Koch FP, Taylor KY, Al-Nawas B, Walter C. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes\u2013in vitro study. Clin Oral Investig. 2012;16(1):87\u201393. https:\/\/doi.org\/10.1007\/s00784-010-0507-6.","journal-title":"Clin Oral Investig"},{"issue":"3","key":"4331_CR17","first-page":"0116","volume":"4","author":"T Papamitsou","year":"2018","unstructured":"Papamitsou T, Fotiadou S, Papachristodoulou A, Dietrich EM, Kamperis D, Toskas A, et al. Effect of alendronic acid on buccal mucosa. J Dent Oral Health. 2018;4(3):0116.","journal-title":"J Dent Oral Health"},{"issue":"10","key":"4331_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.adaj.2017.07.032","volume":"148","author":"MW Lingen","year":"2017","unstructured":"Lingen MW, Abt E, Agrawal N, et al. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dent Assoc. 2017;148(10):712\u2013e727710.","journal-title":"J Am Dent Assoc"},{"issue":"5","key":"4331_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2133.1984.tb06629.x","volume":"111","author":"JB Matthews","year":"1984","unstructured":"Matthews JB, Scully CM, Potts AJ. Oral lichen planus: an immunoperoxidase study using monoclonal antibodies to lymphocyte subsets. Br J Dermatol. 1984;111(5):587\u201395.","journal-title":"Br J Dermatol"},{"issue":"2","key":"4331_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.clim.2006.10.007","volume":"122","author":"V Calabresi","year":"2007","unstructured":"Calabresi V, Carrozzo M, Cozzani E, et al. Oral pemphigoid autoantibodies preferentially target BP180 ectodomain. Clin Immunol. 2007;122(2):207\u201313.","journal-title":"Clin Immunol"},{"issue":"1","key":"4331_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0030-4220(68)90194-1","volume":"25","author":"JO Andreasen","year":"1968","unstructured":"Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol. 1968;25(1):31\u201342.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"11","key":"4331_CR22","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1053\/joms.2000.16630","volume":"58","author":"S Silverman Jr","year":"2000","unstructured":"Silverman S Jr. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg. 2000;58(11):1286\u20138.","journal-title":"J Oral Maxillofac Surg"},{"key":"4331_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/1055-9965.EPI-09-0699","volume":"19","author":"P Shi","year":"2010","unstructured":"Shi P, Liu W, Zhou ZT, He QB, Jiang WW. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Cancer Epidemiol Biomarkers Prev. 2010;19:844\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"4331_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/sj.ebd.6401349","volume":"19","author":"D Richards","year":"2018","unstructured":"Richards D. Malignant transformation rates in oral lichen planus. Evid Based Dent. 2018;19(4):122.","journal-title":"Evid Based Dent"},{"issue":"4","key":"4331_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/odi.13323","volume":"27","author":"MA Gonzalez-Moles","year":"2021","unstructured":"Gonzalez-Moles MA, Warnakulasuriya S, Gonzalez-Ruiz I, et al. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2021;27(4):813\u201328.","journal-title":"Oral Dis"},{"issue":"1","key":"4331_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14219\/jada.2013.10","volume":"145","author":"SG Fitzpatrick","year":"2014","unstructured":"Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014;145(1):45\u201356.","journal-title":"J Am Dent Assoc"},{"key":"4331_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jop.12996","volume":"50","author":"M Idrees","year":"2021","unstructured":"Idrees M, Kujan O, Shearston K, Farah CS. Oral lichen planus has a very low malignant transformation rate: a systematic review and meta-analysis using strict diagnostic and inclusion. J Oral Pathol Med. 2021;50:287\u201398.","journal-title":"J Oral Pathol Med."},{"issue":"4","key":"4331_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4331_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0001-7310(09)70063-8","volume":"100","author":"M Garcia-Font","year":"2009","unstructured":"Garcia-Font M, Curco N, Prat C, Vives P. [Mouth sores caused by alendronate]. Actas Dermosifiliogr. 2009;100(1):77\u20138.","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"4331_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg. 2008;66(5):839\u201347. PMID: 18423269; PMCID: PMC2426967.","journal-title":"J Oral Maxillofac Surg"},{"key":"4331_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.7243\/2055-091X-2-24","volume":"2","author":"E-M Dietrich","year":"2015","unstructured":"Dietrich E-M, Theodora P, Antonia S, Georgios K, Esthelle N. Ultrastructural alterations of the inferior alveolar nerve in wistar rats after alendronate administration per os: hypothesis for the generation of the \u201cnumb chin syndrome\u201d. J Histol Histopathol. 2015;2:24. http:\/\/dx.doi.org\/10.7243\/2055-091X-2-24.","journal-title":"J Histol Histopathol"},{"issue":"10","key":"4331_CR32","first-page":"519","volume":"58","author":"M Carrozzo","year":"2009","unstructured":"Carrozzo M, Thorpe R. Oral lichen planus: a review. Minerva Stomatol. 2009;58(10):519\u201337.","journal-title":"Minerva Stomatol"},{"issue":"2","key":"4331_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamadermatol.2019.3797","volume":"156","author":"C Li","year":"2020","unstructured":"Li C, Tang X, Zheng X, et al. Global prevalence and incidence estimates of oral lichen planus: a systematic review and meta-analysis. JAMA Dermatol. 2020;156(2):172\u201381.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"4331_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/ijerph19010253","volume":"19","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Kusiak A, Ossowska A, Grzybowska ME. Changes in the oral cavity in menopausal women-a narrative review. Int J Environ Res Public Health. 2021;19(1):253. https:\/\/doi.org\/10.3390\/ijerph19010253. Published 2021 Dec 27.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"4331_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.medcli.2017.06.024","volume":"149","author":"MJ Garcia-Pola","year":"2017","unstructured":"Garcia-Pola MJ, Gonzalez-Alvarez L, Garcia-Martin JM. Treatment of oral lichen planus. Systematic review and therapeutic guide. Med Clin (Barc). 2017;149(8):351\u201362.","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"4331_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ger.12590","volume":"39","author":"C Psimma","year":"2022","unstructured":"Psimma C, Psimma Z, Willems HC, Kl\u00fcter WJ, van der Maarel-Wierink CD. Oral bisphosphonates: adverse effects on the oral mucosa not related to the jaw bones. A scoping review. Gerodontology. 2022;39(4):330\u20138. https:\/\/doi.org\/10.1111\/ger.12590.","journal-title":"Gerodontology"},{"issue":"4","key":"4331_CR37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4103\/jomfp.jomfp_229_21","volume":"26","author":"PR Sarkate","year":"2022","unstructured":"Sarkate PR, Pathak JR, Patel S, Swain N, Sahu NK. Comparative evaluation of prevalence and phenotypic variations of Candida species in patients of oral lichen planus and oral lichenoid lesions with healthy individuals - a prospective microbiological study. J Oral Maxillofac Pathol. 2022;26(4):590. https:\/\/doi.org\/10.4103\/jomfp.jomfp_229_21.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"1","key":"4331_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12903-020-01118-2","volume":"20","author":"NR Amin","year":"2020","unstructured":"Amin NR, Yussif N, Ahmed E. The effect of smoking on clinical presentation and expression of TLR-2 and CD34 in oral lichen planus patients: clinical and immunohistochemical study. BMC Oral Health. 2020;20(1):129. https:\/\/doi.org\/10.1186\/s12903-020-01118-2. Published 2020 Apr 29.","journal-title":"BMC Oral Health"},{"issue":"3","key":"4331_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1601-0825.2008.01441.x","volume":"14","author":"MA Gonzalez-Moles","year":"2008","unstructured":"Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14(3):229\u201343. https:\/\/doi.org\/10.1111\/j.1601-0825.2008.01441.x.","journal-title":"Oral Dis"},{"issue":"1","key":"4331_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijms22010053","volume":"22","author":"S Zhu","year":"2020","unstructured":"Zhu S, H\u00e4ussling V, Aspera-Werz RH, et al. Bisphosphonates reduce smoking-induced osteoporotic-like alterations by regulating RANKL\/OPG in an osteoblast and osteoclast co-culture model. Int J Mol Sci. 2020;22(1):53. https:\/\/doi.org\/10.3390\/ijms22010053. Published 2020 Dec 23.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4331_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15407\/ubj91.03.078","volume":"91","author":"LO Metelytsia","year":"2019","unstructured":"Metelytsia LO, Hodyna DM, Kobzar OL, Kovalishyn VV, Semenyuta IV. New anti-candida active nitrogen-containing bisphosphonates as inhibitors of farnesyl pyrophosphate synthase Candida albicans. Ukr Biochem J. 2019;91(3):78\u20139. https:\/\/doi.org\/10.15407\/ubj91.03.078.","journal-title":"Ukr Biochem J"},{"issue":"8","key":"4331_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40618-014-0110-9","volume":"37","author":"GR Williams","year":"2014","unstructured":"Williams GR. Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine? J Endocrinol Invest. 2014;37(8):775\u20139. https:\/\/doi.org\/10.1007\/s40618-014-0110-9.","journal-title":"J Endocrinol Invest"},{"key":"4331_CR43","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fendo.2017.00310","volume":"8","author":"D Li","year":"2017","unstructured":"Li D, Li J, Li C, Chen Q, Hua H. The association of thyroid disease and oral lichen planus: a literature review and meta-analysis. Front Endocrinol (Lausanne). 2017;8:310. https:\/\/doi.org\/10.3389\/fendo.2017.00310. Published 2017 Nov 9.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4331_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/0019-5154.156315","volume":"60","author":"S Gupta","year":"2015","unstructured":"Gupta S, Jawanda MK. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J Dermatol. 2015;60(3):222\u20139. https:\/\/doi.org\/10.4103\/0019-5154.156315.","journal-title":"Indian J Dermatol"},{"issue":"1\u20133","key":"4331_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12026-012-8302-x","volume":"54","author":"A Hasham","year":"2012","unstructured":"Hasham A, Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res. 2012;54(1\u20133):204\u201313. https:\/\/doi.org\/10.1007\/s12026-012-8302-x.","journal-title":"Immunol Res"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04331-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T14:03:13Z","timestamp":1715349793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4331"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04331-5","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of the Goethe University, Frankfurt, Germany \u201cEthik-Kommission des Fachbereichs Medizin der Goethe-Universit\u00e4t c\/o Universit\u00e4tsklinikum\u201d (IRB approval number: 20-1032) and conducted in accordance with the Helsinki Declaration, as revised in 2013. Written informed consent was obtained from all the participants for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"547"}}